MicroTransponder Vivistim nerve stim tech delivers positive stroke outcomes
MicroTransponder recently announced positive real-world outcomes for its Vivistim vagus nerve stimulation (VNS) system. Data highlighted Vivistim’s impact when paired with occupational or physical therapy to help ischemic stroke survivors improve hand and arm function. The study demonstrated 2-3 times... Read More →
European Brain Surgery Start-Up Seeks US Expansion featuring Robeauté
Robeauté, a start-up which promises to transform brain surgeries with microrobots the size of a grain of rice, has raised $28 million in its latest funding round. Co-founder and COO Joana Cartocci spoke to Bloomberg’s Tom Mackenzie about the challenges... Read More →
Arsenal Medical Announces Complete Enrollment of the Initial Cohort in the EMBO-02 Study Assessing NeoCast™ for the Treatment of Chronic Subdural Hematoma
WALTHAM, Mass. — Arsenal Medical, a clinical-stage company developing medical devices from innovative biomaterials, today announced the complete enrollment of an initial cohort of 10 patients in the EMBO-02 clinical study of NeoCast™ to treat chronic subdural hematomas (cSDH) across... Read More →
Medtech Pioneers: Lisa Carmel sits down with Maria Artunduaga, founder and CEO of Samay
In Medtech Pioneers episode 8, Lisa Carmel sits down with Maria Artunduaga, MD, MPH, MTM, founder and CEO of Samay — The Winner of the 2024 MedTech Innovator Grand Prize focused on building hardware, software, and a data analytics platform... Read More →
Gyder Surgical Announces 510(k) FDA clearance for the GYDER® Hip System, the World’s First Commercially Available Pin-less and Image-less Solution for Accurate Positioning of the Acetabular Cup during Anterior Hip Arthroplasty
MULGRAVE, Australia & PALO ALTO, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) — Gyder Surgical, a MedTech company specializing in intuitive, orthopaedic navigation solutions, today announced the 510(k) FDA clearance for the GYDER® Hip System, the world’s first commercially available non-invasive... Read More →
Ryght AI and Cancer Research SA (CRSA) Partner to Enhance Cancer Clinical Trials in South Australia
LAGUNA BEACH, Calif., Jan. 28, 2025 /PRNewswire/ — Ryght AI, a leading provider of real-time generative AI solutions for the clinical research industry, and Cancer Research South Australia (CRSA), a premier cancer care provider, have announced a strategic partnership to... Read More →
Multi-institutional team applies TIMING to explain differences in tumor rejection kinetics featuring CellChorus®
Differences in dynamics explain the distinct cytolytic behavior of CAR T cell therapy and can guide engineering of more adaptive and effective cellular products HOUSTON, Texas — January 28, 2025. CellChorus®, the leader in applying artificial intelligence to visually evaluate... Read More →
AIIMS Jammu Collaborates With 4baseCare To Establish Centre For Advanced Genomics & Precision Medicine
AIIMS Jammu has partnered with 4baseCare to launch the Centre for Advanced Genomics and Precision Medicine, marking a significant step forward in the integration of genomic technologies into patient care. By leveraging advanced and precision-driven solutions, this facility aims to... Read More →
AccurKardia Earns FDA Breakthrough Device Designation for AK+ Guard™
AccurKardia, a pioneer in ECG-based diagnostics technology, has announced a major milestone: the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its AK+ Guard™ hyperkalemia detection software. This investigational technology leverages Lead I ECG data to... Read More →
A Promise to My Mother: Building a Better Future for Chronic Care featuring Aidar Health
Today marks one year since my mother, Viji, passed away. She was the inspiration behind Aidar Health, the driving force behind everything I’ve worked for, and a shining example of resilience, love, and determination. While her passing has left a... Read More →